FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Spectral AI, Inc. Stock AnalysisComprehensive stock analysis for Spectral AI, Inc. (MDAI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMDAI
MDAI
Spectral AI, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDAI
Home🔹Stocks🔹Spectral AI, Inc.

Spectral AI, Inc.

🇺🇸MDAI•NASDAQ

Spectral AI, Inc.

🇺🇸MDAI•NASDAQ
Market cap
$50.92M
Sentiment

Your view on MDAI

Mkt Cap
$50.92M
Sentiment
Your view
MDAI
Spectral AI, Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDAI
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Spectral AI, Inc.

Industry
Medical - Specialties
Sector
Healthcare
CEO
Wensheng Fan
Headquarters
2515 McKinney Avenue, Dallas, TX, US
Industry
Medical - Specialties
Sector
Healthcare
CEO
Wensheng Fan
Headquarters
2515 McKinney Avenue, Dallas, TX, US
Description

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.

Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Spectral AI, Inc., and the rating behind it. MDAI last traded at $1.60; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Spectral AI, Inc.. Starting points for Spectral AI, Inc.: EPS -$0.33, beta 1.18 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Spectral AI, Inc.. Spectral AI, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Spectral AI, Inc.. Trailing twelve-month EPS for Spectral AI, Inc. stands at -$0.33. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Spectral AI, Inc.. Spectral AI, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Spectral AI, Inc. valued side by side against its closest peers. Spectral AI, Inc. is measured against Medical - Specialties peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Spectral AI, Inc., and how their positions are changing. At a $50.9M market value, institutional positions materially move Spectral AI, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Spectral AI, Inc. executives and directors. Shares of Spectral AI, Inc. have traded between $1.01 and $3.25 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Spectral AI, Inc.. Spectral AI, Inc. is a $50.9M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Spectral AI, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Spectral AI, Inc.. Coverage tracks Spectral AI, Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • CTSO — Cytosorbents Corporation
  • ECOR — electroCore, Inc.
  • EQ — Equillium, Inc.
  • ICCM — IceCure Medical Ltd
  • IPSC — Century Therapeutics, Inc.
  • KPTI — Karyopharm Therapeutics Inc.
  • SRTS — Sensus Healthcare, Inc.

More Medical - Specialties companies

  • ITOC — iTonic Holdings Ltd.
  • KKUR — ChromoCure, Inc.
  • LAB — Standard BioTools Inc.
  • LANZ — Lancer Orthodontics, Inc.
  • LDX.AX — Lumos Diagnostics Holdings Limited
  • LDXHF — Lumos Diagnostics Holdings Limited
  • LLBO — Lifeline Biotechnologies, Inc.
  • MASS — 908 Devices Inc.
  • MEDGF — Medacta Group S.A.
  • MLAB — Mesa Laboratories, Inc.
  • MOBI — Mobia Medical, Inc. Common Stock
  • NSCIF — Nanalysis Scientific Corp.

ETFs holding Spectral AI, Inc.

  • IWC — iShares Micro-Cap ETF (0.01%)
  • VXF — Vanguard Extended Market ETF (0.00%)
  • VUS.TO — Vanguard U.S. Total Market Index ETF (CAD-hedged) (0.00%)
  • VUN.TO — Vanguard U.S. Total Market Index ETF (0.00%)
  • VTS.AX — Vanguard U.S. Total Market Shares Index ETF (0.00%)
  • VTI — Vanguard Total Stock Market ETF (0.00%)

News

Latest Market News